Search
for

    GlossaryCXCL11

    chemokine that attracts T-cells to inflammation sites

    CXCL11, also known as Interferon-inducible T-cell alpha chemoattractant (I-TAC), is a type of chemokine—a small protein involved in immune responses. It plays a crucial role in attracting T-cells to sites of inflammation or infection, helping the body to fight off pathogens.

    Related Terms

    Learn

    0 / 0 results
    — no results

    Research

    5 / 526 results

    Community Join

    5 / 6 results

      community Seriously confused about minoxidil's method of action

      in Minoxidil  6 upvotes 2 years ago
      The conversation discusses confusion about how Minoxidil promotes hair growth compared to other substances like Menthol, which have similar actions. The user mentions personal positive results with peppermint oil extract and is currently trying L-citrulline for its vasodilation effects.

      community New Treatments, and a Huge Group Buy with Lots of Research

      in Research/Science  109 upvotes 1 year ago
      A user is organizing a group buy for various compounds aimed at reversing hair loss and gray hair, and improving brain health and fat loss. The user has developed a treatment plan based on extensive research and is inviting others to participate, with the option to choose only the compounds they need.

      community How does dutasteride regrowth work?

      in Finasteride/Dutasteride  6 upvotes 6 months ago
      A 25-year-old man with hair loss from bleach damage is using oral minoxidil and considering adding Dutasteride for better regrowth and prevention. He seeks advice on Dutasteride's effectiveness and potential benefits over finasteride, and is also curious about RU58841.

      community Stop expecting results in 2 months!

      in Treatment  125 upvotes 6 months ago
      People discussing hair loss treatments emphasize the need for patience, as results from using finasteride and minoxidil can take 8-12 months or longer. Some users report early signs of improvement, while others experience continued shedding or slower progress.